Opinion

How India’s National Biobank can power next frontier in healthcare

In 1996, the term biobank was first used by researchers Steffen Loft and Henrik Enghusen Poulsen to describe t...

09 October, 2025 | Thursday | Views

Medtech

Motorica launches Digital Prosthetics Programme in India

Motorica, a global medtech company specialising in assistive technologies and medical cybernetics, has officia...

09 October, 2025 | Thursday | News

Start-Ups

DineOut founders secure $4.5 M for medical travel startup

Dineout Founders Ankit Mehrotra and Sahil Jain have secured $4.5 million in a seed funding roun...

07 October, 2025 | Tuesday | News

Inside Magazine

India's Pharma Reforms Target Global Credibility

The Indian government has introduced several measures to simplify drug approvals and support innovation. Key reforms include updating the New Drug and Clinical Trial Rules (2019) and using digital platforms to handle regulatory submissions, with the goal of improving transparency, reducing approval timelines, strengthening pharmacovigilance, and maintaining quality standards. What do these reforms entail, how is the industry responding, and what steps lie ahead to make India’s pharmaceutical sector globally competitive?

For Feedback, please email us at: communications@mmactiv.com

Sign up here to access BioSpectrum India Flip Book.

Sign up here to access BioSpectrum India Flip Book

Videos

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy